| Literature DB >> 36247976 |
Christina Yek1,2, Andrea R Pacheco3, Manu Vanaerschot4, Jennifer A Bohl5, Elizabeth Fahsbender4, Andrés Aranda-Díaz4,6, Sreyngim Lay3, Sophana Chea3, Meng Heng Oum3, Chanthap Lon3, Cristina M Tato4, Jessica E Manning2,3.
Abstract
Metagenomic next-generation sequencing (mNGS) is the process of sequencing all genetic material in a biological sample. The technique is growing in popularity with myriad applications including outbreak investigation, biosurveillance, and pathogen detection in clinical samples. However, mNGS programs are costly to build and maintain, and additional obstacles faced by low- and middle-income countries (LMICs) may further widen global inequities in mNGS capacity. Over the past two decades, several important infectious disease outbreaks have highlighted the importance of establishing widespread sequencing capacity to support rapid disease detection and containment at the source. Using lessons learned from the COVID-19 pandemic, LMICs can leverage current momentum to design and build sustainable mNGS programs, which would form part of a global surveillance network crucial to the elimination of infectious diseases.Entities:
Keywords: COVID-19; LMIC; Metagenomics; biosurveillance; next-generation sequencing
Year: 2022 PMID: 36247976 PMCID: PMC9558322 DOI: 10.3389/fepid.2022.926695
Source DB: PubMed Journal: Front Epidemiol ISSN: 2674-1199